Your Top-Tier
IP Litigation Experts.
Over the past three decades, Luthi & Co. has established itself as Israel’s leading IP litigation firm – spearheading the majority of high-profile IP cases in the country. As a trusted and experienced partner, we have earned a sterling reputation for our unparalleled expertise both locally and abroad.
Our Services
We provide top-tier legal services encompassing all areas of
IP litigation and monetization, including patents, designs, copyright, and trademarks.
- IP Litigation & Dispute Resolution
- Cross Border Patent Litigation
- Opposition & Revocation Proceedings
- Patent Term Extension
- Arbitration
- Domain Name
- Regulatory Affairs & Compliance
- IP Licensing, Transactions & Joint Ventures
- Patent Monetization
- Franchising
Our Team
Daniel Lerner
Attorney at Law, Partner
Lin Safadi
Attorney at Law, Associate
Martin Binnes
Attorney at Law, Partner
Motar Pelled
Attorney at Law, Associate
Richard Luthi
Attorney at Law, Partner
Rotem Cohen
Attorney at Law, Senior Associate
Recognition & Rankings
Owing to our unparalleled litigation expertise, Luthi & Co. is consistently being recognized by
leading professional ranking organizations and industry publications around the world.
News & Insights
-
Announcing: Herzog Patents – CDS-LUTHI
We are very pleased and proud to announce that as of today, The CDS-LUTHI Group is teaming up with the law firm of Herzog Fox & Neeman, one of the largest and leading law firms in Israel to form – Herzog Patents in association with CDS-LUTHI. The two arms of the CDS-LUTHI… -
Israel Trademark Landscape 2024: Key Trends and Developments
The Israel Patent Office (ILPO) recently released its 2024 Annual Report, providing insight into the trends and developments across patents, trademarks, and designs. Below, we highlight the main takeaways regarding trademarks. Improved Processing Times The Israeli trademark registration landscape underwent significant shifts in 2024, characterized by… -
EU Launches New Transparency Rules for Generative AI: The Intellectual Property Perspective, and What Israel-Based Clients Should Know
The European Union’s transparency rules for generative AI, effective August 2, 2025, introduce specific requirements for how AI systems handle intellectual property rights. These regulations require developers to document their training data sources, implement measures to prevent copyright infringement, and disclose when content is AI-generated. The new rules require AI… -
Patent Application Claim Strategies Are Essential to Strong Patents
Strategic claim drafting and prosecution in the USPTO continues to be of paramount importance. This is especially true in view of the recent U.S. Court of Appeals for the Federal Circuit (CAFC) opinion Colibri Heart Valve LLC v. Medtronic CoreValve, LLC, No. 2023-2153 (Fed. Cir. July 18, 2025) . -
Overcoming Section 101 Rejections for Patent Eligible Subject Matter
Securing a patent in the U.S. can be challenging—especially when your invention is met with a Section 101 rejection for not being “patent-eligible.” These rejections typically assert that the claimed subject matter is abstract and lacks an “inventive concept.” However, with a strategic approach, this rejection can be overcome. This… -
Game-Changer Decision from the EPO: the “On-Sale” bar to patentability now exists in Europe
By Dr. Ilan Cohn The Decision On July 2, 2025, the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) delivered a landmark decision that reshapes the applicability of prior sale as prior art for determining patentability. It was previously thought that in Europe (and in many other… -
USPTO Changes Rules for Advancement of Examination by Changing Accelerated Examination Qualifications
Written by Jerome R. Smith (Senior Patent Attorney) Effective July 10, 2025 The United States Patent and Trademark Office (USPTO) has announced important changes to its Accelerated Examination procedures, effective July 10, 2025. Advancement is available, but most requests will require fees. Advancement of Examination is available in the…
